CS Diagnostics Corp. (CSDX) Fair Value 2026

CSDX · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.5 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, CS Diagnostics Corp. (CSDX) trades at $0.01. QOC: 4.5/10. Value Trap Risk: 0/100 (SAFE). 1/13 models active.

Key Facts

Ticker
CSDX
Price
$0.01
Quality Score
4.5/10
Value Trap Risk
0/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.5/10 signals weak fundamentals

What Fair Value Does Each Model Give CSDX?

1 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Low Conviction
 $0.01 -42.4%

All Models Active

All 1 models are displayed above.

What Is CS Diagnostics Corp. (CSDX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, CS Diagnostics Corp.'s intrinsic value is estimated at $0.01. Trading at its current price of $0.01, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -42.4%.

What Do the Models Say About CSDX?

1 of 13 models are currently active for CSDX. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does CSDX Rank in Medical Devices?

Among 157 Medical Devices stocks, CSDX ranks #134 by Quality of Company score. CirclFi's QOC score of 4.5/10 evaluates 32 fundamental signals. A score of 4.5 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

CS Diagnostics Corp.'s positioning within the Medical Devices segment means that revenue per drug plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.

Is CSDX a Value Trap?

CirclFi's Value Trap algorithm assigns CSDX a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for CS Diagnostics Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, CS Diagnostics Corp. earns a quality score of 4.5/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CSDX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CSDX's 1 active models, average confidence is 11%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy CS Diagnostics Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

RBOTVicarious Surgical Inc.QOC 4.6POASPhaos Technology Holdings (CaymQOC 4.5PAVMPAVmed Inc.QOC 4.6MODDModular Medical, Inc.QOC 4.4RMSLREMSleep Holdings, Inc.QOC 4.6BJDXBluejay Diagnostics, Inc.QOC 4.4SNNSmith & Nephew plcQOC 8.7ATECAlphatec Holdings, Inc.QOC 6.9XAIRBeyond Air, Inc.QOC 5.8IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: RBOT · POAS · PAVM · MODD · RMSL · BJDX · SNN · ATEC · XAIR · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to CSDX?

7 companies across all industries closest to CSDX’s Quality of Company score of 4.5/10.

COSMCosmos Health Inc.QOC 4.5ENSCEnsysce Biosciences, Inc.QOC 4.5AETNAeternum Health Inc.QOC 4.5BOLDBoundless Bio, Inc.QOC 4.5ELDNEledon Pharmaceuticals, Inc.QOC 4.5ANYSphere 3D Corp.QOC 4.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: COSM · ENSC · AETN · BOLD · ELDN · ANY · NVDA

Where Does CSDX Sit in CirclFi's Medical Devices Rankings?

CSDX is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About CS Diagnostics Corp.’s Valuation?

What is CS Diagnostics Corp.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for CS Diagnostics Corp. (CSDX). The Quality of Company score is 4.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CSDX overvalued or undervalued right now?

At $0.01, 0 of 1 active models suggest CSDX may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits CS Diagnostics Corp.'s business model in Medical Devices.

What does a Quality of Company score of 4.5 mean for CSDX?

CS Diagnostics Corp.'s QOC of 4.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on CSDX?

CirclFi analyzes CSDX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is CSDX a value trap in 2026?

CS Diagnostics Corp.'s Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns CS Diagnostics Corp. (CSDX) a Quality of Company score of 4.5/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/CSDX/ · Methodology
Primary sources for this CSDX valuation
  • Financial statements: CS Diagnostics Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001106861) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CSDX as of ; valuations recomputed .